USANA Health Sciences (NYSE:USNA) Sets New 52-Week Low – Time to Sell?

USANA Health Sciences, Inc. (NYSE:USNA)’s stock price reached a new 52-week low during trading on Tuesday . The stock traded as low as $26.74 and last traded at $26.87, with a volume of 26579 shares. The stock had previously closed at $27.24.

Wall Street Analyst Weigh In

Several research analysts have recently commented on USNA shares. StockNews.com downgraded USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 14th. DA Davidson decreased their target price on shares of USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating on the stock in a research note on Thursday, February 27th. Finally, Sidoti downgraded shares of USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a report on Tuesday, February 18th.

USANA Health Sciences Trading Down 2.2 %

The business’s 50 day simple moving average is $31.67 and its 200 day simple moving average is $35.33. The firm has a market capitalization of $503.67 million, a PE ratio of 9.38, a PEG ratio of 0.93 and a beta of 0.98.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $0.64 earnings per share for the quarter, beating analysts’ consensus estimates of $0.49 by $0.15. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. The business had revenue of $213.61 million for the quarter, compared to analysts’ expectations of $208.82 million. Analysts forecast that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.

Insider Transactions at USANA Health Sciences

In other USANA Health Sciences news, insider David Mulham Mulham sold 3,234 shares of the firm’s stock in a transaction on Monday, March 10th. The stock was sold at an average price of $32.98, for a total transaction of $106,657.32. Following the transaction, the insider now directly owns 12,775 shares in the company, valued at $421,319.50. This trade represents a 20.20 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Jim Brown sold 5,000 shares of the stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $29.47, for a total value of $147,350.00. Following the transaction, the chief executive officer now directly owns 15,716 shares in the company, valued at $463,150.52. The trade was a 24.14 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 15,920 shares of company stock worth $500,285. 0.33% of the stock is currently owned by company insiders.

Institutional Trading of USANA Health Sciences

A number of hedge funds have recently bought and sold shares of USNA. R Squared Ltd purchased a new position in shares of USANA Health Sciences in the 4th quarter valued at $28,000. Safe Harbor Fiduciary LLC acquired a new position in shares of USANA Health Sciences during the third quarter worth $30,000. KLP Kapitalforvaltning AS acquired a new position in shares of USANA Health Sciences during the fourth quarter valued at about $83,000. Quantbot Technologies LP purchased a new position in shares of USANA Health Sciences in the fourth quarter worth $132,000. Finally, Meeder Asset Management Inc. acquired a new stake in USANA Health Sciences during the 4th quarter worth about $143,000. Hedge funds and other institutional investors own 54.25% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.